Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers
炎症评分在接受 CD3×CD20 双特异性 T 细胞衔接器治疗的复发/难治性大B细胞淋巴瘤患者中的预后价值
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025017766
Magno, Giulia; Rejeski, Kai; Rappa, Giulia; Stock, Sophia; Holzem, Alessandra; Landwehr, Maria; Seib, Maximilian; Kutsch, Nadine; Mammadova, Jamila; Mayer, Stephanie; Aumann, Shlomzion; Van Ham, Jonas; Ringelstein-Harlev, Shimrit; Velazquez, Giuliano Filippini; Wurm-Kuczera, Rebecca; Scholz, Julia Katharina; Greenbaum, Uri; Raj, Sandeep S; Shouval, Roni; Müller, Fabian; Chapuy, Björn; Schmid, Christoph; Beyar-Katz, Ofrat; Vergote, Vibeke K J; Poeck, Hendrik; Dong, Ning; Holtick, Udo; Ram, Ron; Pabst, Thomas; Shumilov, Evgenii; Lenz, Georg; Iacoboni, Gloria; Barba, Pere; Bücklein, Veit; Subklewe, Marion
B细胞
炎症
T细胞
炎症/感染
淋巴瘤
CD3
CD20
细胞生物学
CD2
免疫/内分泌